Sepsis carries a high mortality among hospitalised adults in Malawi in the eraofantiretroviral therapy scale-up: Alongitudinal cohort study

Journal of Infection

Volumn 70, Issue 1, 2015, Pages 11-19

  Waitt, Peter I ^a   Mukaka, Mavuto ^a   Goodson, Patrick ^a   SimuKonda, Felanji D ^a   Waitt, Catriona J ^a   Feasey, Nick ^a   Allain, Theresa J ^a   Downie, Paul ^a   Heyderman, Robert S ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

Author keywords

Adults; Africa; Antiretroviral therapy; Bacteraemia; HIV; Sepsis

Indexed keywords

ANTIRETROVIRUS AGENT; CEFTRIAXONE; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BREATHING RATE; CAPILLARY FLOW; CEREBROSPINAL FLUID CULTURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; GLASGOW COMA SCALE; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPOTENSION; HYPOXIA; INFECTION RISK; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALAWI; MALE; MORTALITY; OXYGEN SATURATION; PROSPECTIVE STUDY; PULSE RATE; RISK ASSESSMENT; SEPSIS; SYSTOLIC BLOOD PRESSURE; TEACHING HOSPITAL; THROMBOCYTE COUNT; BACTEREMIA; COMPLICATION; EPIDEMIOLOGY; HIV INFECTIONS; HOSPITALIZATION; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PUBLIC HOSPITAL; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-RETROVIRAL AGENTS; BACTEREMIA; CEFTRIAXONE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HOSPITALIZATION; HOSPITALS, PUBLIC; HUMANS; LONGITUDINAL STUDIES; MALAWI; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEPSIS; YOUNG ADULT;

EID: 84916939630     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.07.004     Document Type: Article

References (39)

1. SanJoaquin M.A., Allain T.J., Molyneux M.E., Benjamin L., Everett D.B., Gadabu O., et al. Surveillance Programme of IN-patients and Epidemiology (SPINE): implementation of an electronic data collection tool within a large hospital in Malawi. PLoS Med 2013 Mar, 10(3). e1001400.
2. Peters R.P., Zijlstra E.E., Schijffelen M.J., Walsh A.L., Joaki G., Kumwenda J.J., et al. A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management. Trop Med Int Health 2004 Aug, 9(8):928-934.
3. Gordon M.A., Walsh A.L., Chaponda M., Soko D., Mbvwinji M., Molyneux M.E., et al. Bacteraemia and mortality among adult medical admissions in Malawi-predominance of non-typhi salmonellae and Streptococcus pneumoniae. J Infect 2001 Jan, 42(1):44-49.
4. Jacob S.T., Moore C.C., Banura P., Pinkerton R., Meya D., Opendi P., et al. Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population. PLoS One 2009, 4(11). e7782.
5. Bone R.C., Sibbald W.J., Sprung C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992 Jun, 101(6):1481-1483.
6. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003 Apr, 31(4):1250-1256.
7. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008 Jan, 36(1):296-327.
8. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013 Feb, 41(2):580-637.
9. Chamberlain D.J., Willis E.M., Bersten A.B. The severe sepsis bundles as processes of care: a meta-analysis. Aust Crit Care 2011 Nov, 24(4):229-243.
10. Jacob S.T., Lim M., Banura P., Bhagwanjee S., Bion J., Cheng A.C., et al. Integrating sepsis management recommendations into clinical care guidelines for district hospitals in resource-limited settings: the necessity to augment new guidelines with future research. BMC Med 2013, 11:107.
11. Cheng A.C., West T.E., Limmathurotsakul D., Peacock S.J. Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med 2008 Aug 19, 5(8). e175.
12. Becker J.U., Theodosis C., Jacob S.T., Wira C.R., Groce N.E. Surviving sepsis in low-income and middle-income countries: new directions for care and research. Lancet Infect Dis 2009 Sep, 9(9):577-582.
13. Baelani I., Jochberger S., Laimer T., Otieno D., Kabutu J., Wilson I., et al. Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers. Crit Care 2011, 15(1):R10.
14. Kellum J.A., Pinsky M.R. Use of vasopressor agents in critically ill patients. Curr Opin Crit Care 2002 Jun, 8(3):236-241.
15. Scaradavou A. HIV-related thrombocytopenia. Blood Rev 2002 Mar, 16(1):73-76.
16. Peltier J.Y., Lambin P., Doinel C., Courouce A.M., Rouger P., Lefrere J.J. Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a 5-year prospective study. AIDS 1991 Apr, 5(4):381-384.
17. Treatment of tuberculosis: guidelines 2010, Geneva. 4th ed.
18. Gordon M.A., Graham S.M., Walsh A.L., Wilson L., Phiri A., Molyneux E., et al. Epidemics of invasive Salmonella enteritidis serovar enteritidis and S. Typhimurium infections among adults and children, associated with multidrug resistance in Malawi. Clin Infect Dis 2008, 46:963-969.
19. Everett D.B., Mukaka M., Denis B., Gordon S.B., Carrol E.D., van Oosterhout J.J., et al. Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. PLoS One 2011, 6(3). e17765.
20. Barrow G.I. Cowan and Steel's manual for the identification of medical bacteria 2004, 3rd ed.
21. Jacob S.T., Banura P., Baeten J.M., Moore C.C., Meya D., Nakiyingi L., et al. The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: a prospective intervention study. Crit Care Med 2012 Jul, 40(7):2050-2058.
22. Mayanja B.N., Todd J., Hughes P., Van der Paal L., Mugisha J.O., Atuhumuza E., et al. Septicaemia in a population-based HIV clinical cohort in rural Uganda, 1996-2007: incidence, aetiology, antimicrobial drug resistance and impact of antiretroviral therapy. Trop Med Int Health 2010 Jun, 15(6):697-705.
23. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992 Jun, 101(6):1644-1655.
24. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008 Jan, 34(1):17-60.
25. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003 Apr 17, 348(16):1546-1554.
26. WHO Malawi: health statistics profile 2010 2010, Geneva.
27. WHO Treatment of Aids: the 2 year plan to scale up antiretroviral therapy in Malawi Ministry of Health and Population, Malawi 2004, [Contract No.: Document Number].
28. MOH Malawi antiretroviral treatment program 2010, Quarterly Report: Results up to 31st December 2009, [Contract No.: Document Number].
29. Zachariah R., Fitzgerald M., Massaquoi M., Pasulani O., Arnould L., Makombe S., et al. Risk factors for high early mortality in patients on antiretroviral therapy in a rural district of Malawi. AIDS 2006, 20(18):2355-2360.
30. Lawn S.D., Wilkinson R.J., Lipman M.C., Wood R. Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med 2008 Apr 1, 177(7):680-685.
31. Waitt C.J., Peter K.B.N., White S.A., Kampmann B., Kumwenda J., Heyderman R.S., et al. Early deaths during tuberculosis treatment are associated with depressed innate responses, bacterial infection, and tuberculosis progression. J Infect Dis 2011 Aug 1, 204(3):358-362.
32. Lewis D.K., Peters R.P., Schijffelen M.J., Joaki G.R., Walsh A.L., Kublin J.G., et al. Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre, Malawi. Int J Tuberc Lung Dis 2002 Dec, 6(12):1067-1074.
33. Bedell R.A., Anderson S.T., van Lettow M., Akesson A., Corbett E.L., Kumwenda M., et al. High prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi. PLoS One 2012, 7(6). e39347.
34. Feasey N.A., Banada P.P., Howson W., Sloan D.J., Mdolo A., Boehme C., et al. Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosis. J Clin Microbiol 2013 Jul, 51(7):2311-2316.
35. Sloand E.M., Klein H.G., Banks S.M., Vareldzis B., Merritt S., Pierce P. Epidemiology of thrombocytopenia in HIV infection. Eur J Haematol 1992 Mar, 48(3):168-172.
36. Okafor U.V. Challenges in critical care services in Sub-Saharan Africa: perspectives from Nigeria. Indian J Crit Care Med 2009 Jan-Mar, 13(1):25-27.
37. Maitland K., Kiguli S., Opoka R.O., Engoru C., Olupot-Olupot P., Akech S.O., et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011 Jun 30, 364(26):2483-2495.
38. Gao F., Melody T., Daniels D.F., Giles S., Fox S. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 2005, 9(6):R764-R770.
39. Rivers E.P., McIntyre L., Morro D.C., Rivers K.K. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 2005 Oct 25, 173(9):1054-1065.